Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain
- PMID: 2886126
- DOI: 10.1016/0006-2952(87)90594-6
Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain
Abstract
3,4-Methylenedioxymethamphetamine (MDMA) is a recently popularized recreational drug, although some have advocated its psychotherapeutic potential. Since the pharmacology of MDMA is largely uncharacterized, the stereochemical profiles of MDMA and some of its homologs were derived on inhibition of synaptosomal uptake of [3H]monoamines and compared to those of amphetamine and the hallucinogenic phenylisopropylamine 2,5-dimethoxy-4-methylamphetamine (DOM). In contrast to the 5-fold stereoselectivity observed with amphetamine, only the S-(+) enantiomer of MDMA and 3,4-methylenedioxyamphetamine (MDA) inhibited [3H]dopamine uptake into striatal synaptosomes. Neither stereoisomer of the alpha-ethyl homolog of MDMA, N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine (MBDB), inhibited [3H]dopamine uptake. The two stereoisomers of amphetamine and the MDMA-related compounds were equipotent in inhibiting [3H]norepinephrine uptake into hypothalamic synaptosomes. Both stereoisomers of MDMA, MDA and MBDB were potent inhibitors of [3H]serotonin uptake into hippocampal synaptosomes, but only S-(+)-amphetamine produced an appreciable inhibition of [3H]serotonin uptake. Neither stereoisomer of DOM inhibited synaptosomal uptake of any [3H]monoamine. These results suggest that MDMA and its homologs may be more closely related to amphetamine rather than to DOM in their biochemical mode of action. The pronounced effects of the methylenedioxy-substituted compounds on [3H]serotonin and [3H]norepinephrine uptake implicate these neurotransmitters in the pharmacological effects of these drugs.
Similar articles
-
[3H]monoamine releasing and uptake inhibition properties of 3,4-methylenedioxymethamphetamine and p-chloroamphetamine analogues.Eur J Pharmacol. 1991 Jul 23;200(1):9-16. doi: 10.1016/0014-2999(91)90659-e. Eur J Pharmacol. 1991. PMID: 1685125
-
Drug discrimination studies with MDMA and amphetamine.Psychopharmacology (Berl). 1988;95(1):71-6. doi: 10.1007/BF00212770. Psychopharmacology (Berl). 1988. PMID: 2898791
-
Effects of the enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices.Eur J Pharmacol. 1986 Dec 16;132(2-3):269-76. doi: 10.1016/0014-2999(86)90615-1. Eur J Pharmacol. 1986. PMID: 2880735
-
Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons.Pharmacol Biochem Behav. 2008 Aug;90(2):198-207. doi: 10.1016/j.pbb.2007.10.003. Epub 2007 Oct 16. Pharmacol Biochem Behav. 2008. PMID: 18035407 Free PMC article. Review.
-
3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): pharmacology and toxicology in animals and humans.Addiction. 1994 May;89(5):539-51. doi: 10.1111/j.1360-0443.1994.tb03330.x. Addiction. 1994. PMID: 7913850 Review.
Cited by
-
Entactogens: How the Name for a Novel Class of Psychoactive Agents Originated.Front Psychiatry. 2022 Mar 25;13:863088. doi: 10.3389/fpsyt.2022.863088. eCollection 2022. Front Psychiatry. 2022. PMID: 35401275 Free PMC article. Review.
-
Reduced Efficacy of d-Amphetamine and 3,4-Methylenedioxymethamphetamine in Inducing Hyperactivity in Mice Lacking the Postsynaptic Scaffolding Protein SHANK1.Front Mol Neurosci. 2018 Nov 16;11:419. doi: 10.3389/fnmol.2018.00419. eCollection 2018. Front Mol Neurosci. 2018. PMID: 30505269 Free PMC article.
-
Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine.ACS Chem Neurosci. 2018 Oct 17;9(10):2408-2427. doi: 10.1021/acschemneuro.8b00155. Epub 2018 Jul 12. ACS Chem Neurosci. 2018. PMID: 30001118 Free PMC article. Review.
-
Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) and R(-) MDMA on actigraphy-based daytime activity and sleep parameters in rhesus monkeys.Exp Clin Psychopharmacol. 2018 Aug;26(4):410-420. doi: 10.1037/pha0000196. Epub 2018 Jun 25. Exp Clin Psychopharmacol. 2018. PMID: 29939048 Free PMC article.
-
(±)-MDMA and its enantiomers: potential therapeutic advantages of R(-)-MDMA.Psychopharmacology (Berl). 2018 Feb;235(2):377-392. doi: 10.1007/s00213-017-4812-5. Epub 2017 Dec 16. Psychopharmacology (Berl). 2018. PMID: 29248945 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources